“Information equity is a critical part of the whole picture”: Dr. Robert Breiman on COVID-19 vaccine development and distribution

https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/bb/c6/bd/bbc6bd12-29e8-5ddd-8017-3f4de91c23af/mza_15042924640391451077.jpg/600x600bb.jpg

“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with

CHED

11 episodes

2 weeks ago

Dr. David Benkeser talks about analyses of COVID-19 vaccine trials data on the immune response to those vaccines. We also discuss fluctuations in antibody levels and the potential for the trial data analyses to inform decisions on additional vaccine doses.

Medicine

Health & Fitness

RSS

All content for “Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with is the property of CHED and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode/7877215/7877215-1605644525114-6345f6337483.jpg

“Information equity is a critical part of the whole picture”: Dr. Robert Breiman on COVID-19 vaccine development and distribution

“Antibodies are driving a lot of the protection, but it's not the whole story”: A conversation with

20 minutes 10 seconds

5 years ago

“Information equity is a critical part of the whole picture”: Dr. Robert Breiman on COVID-19 vaccine development and distribution

Dr. Robert Breiman talks about where different SARS-CoV-2 vaccines are in development and clinical trials, and considerations for production and distribution related to logistics and equity. How might vaccines be allocated fairly, both in consideration of essential workers and those at higher risk of developing severe COVID-19 outcomes?